Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex J Poot

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 31, 2016
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for <sup>89</sup>Zr-immuno-PETDanielle J Vugts, Chris Klaver, Claudia Sewing, et al.
EJNMMI Research|March 22, 2023
Imaging the TGFβ type I receptor in pulmonary arterial hypertensionLonneke Rotteveel, Alex J Poot, Esther J M Kooijman, et al.
Nuclear Medicine and Biology|May 20, 2023
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptorAntonia Högnäsbacka, Alex J Poot, Esther Kooijman, et al.
Nuclear Medicine and Biology|June 6, 2022
Synthesis and preclinical evaluation of [<sup>11</sup>C]LR111 and [<sup>18</sup>F]EW-7197 as PET tracers of the activin-receptor like kinase-5Lonneke Rotteveel, Kondababu Kurakula, Esther J M Kooijman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2020
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical <sup>89</sup>Zr-immuno-PETMarion Chomet, Maxime Schreurs, Maria J Bolijn, et al.
Frontiers in Medicine|December 16, 2024
Radioimmunotherapy combating biofilm-associated infection <i>in vitro</i>Zijian Ye, Berend van der Wildt, F Ruben H A Nurmohamed, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2022
[<sup>18</sup>F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot studyAtia Samim, Thomas Blom, Alex J Poot, et al.
EJNMMI Research|February 16, 2024
Synthesis and preclinical evaluation of [<sup>11</sup>C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptorAntonia A Högnäsbacka, Alex J Poot, Christophe Plisson, et al.
International Journal of Molecular Sciences|March 11, 2023
Evaluating the Targeting of a <i>Staphylococcus-aureus</i>-Infected Implant with a Radiolabeled Antibody In VivoBruce van Dijk, J Fred F Hooning van Duyvenbode, Lisanne de Vor, et al.
Antibiotics (Basel, Switzerland)|December 30, 2025
Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: <i>Initial In Vivo Proof-of-Concept</i>F Ruben H A Nurmohamed, Kevin J H Allen, Mackenzie E Malo, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine and Molecular Imaging|August 31, 2016
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for <sup>89</sup>Zr-immuno-PETDanielle J Vugts, Chris Klaver, Claudia Sewing, et al.
EJNMMI Research|March 22, 2023
Imaging the TGFβ type I receptor in pulmonary arterial hypertensionLonneke Rotteveel, Alex J Poot, Esther J M Kooijman, et al.
Nuclear Medicine and Biology|May 20, 2023
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptorAntonia Högnäsbacka, Alex J Poot, Esther Kooijman, et al.
Nuclear Medicine and Biology|June 6, 2022
Synthesis and preclinical evaluation of [<sup>11</sup>C]LR111 and [<sup>18</sup>F]EW-7197 as PET tracers of the activin-receptor like kinase-5Lonneke Rotteveel, Kondababu Kurakula, Esther J M Kooijman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2020
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical <sup>89</sup>Zr-immuno-PETMarion Chomet, Maxime Schreurs, Maria J Bolijn, et al.
Frontiers in Medicine|December 16, 2024
Radioimmunotherapy combating biofilm-associated infection <i>in vitro</i>Zijian Ye, Berend van der Wildt, F Ruben H A Nurmohamed, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2022
[<sup>18</sup>F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot studyAtia Samim, Thomas Blom, Alex J Poot, et al.
EJNMMI Research|February 16, 2024
Synthesis and preclinical evaluation of [<sup>11</sup>C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptorAntonia A Högnäsbacka, Alex J Poot, Christophe Plisson, et al.
International Journal of Molecular Sciences|March 11, 2023
Evaluating the Targeting of a <i>Staphylococcus-aureus</i>-Infected Implant with a Radiolabeled Antibody In VivoBruce van Dijk, J Fred F Hooning van Duyvenbode, Lisanne de Vor, et al.
Antibiotics (Basel, Switzerland)|December 30, 2025
Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: <i>Initial In Vivo Proof-of-Concept</i>F Ruben H A Nurmohamed, Kevin J H Allen, Mackenzie E Malo, et al.
Pageof 6